Home Generics Biosimilars Docs & Positions Facts & Figures Press Room Conferences

Generic Medicines | Video

A Video Profile of the European Generic Medicines Industry


CD Cover for the EGA Video

Choose your internet connection:
High Speed (Broadband)  ||  Low Speed (Dial-up Modem)

Read the Video Transcript:
English | Français | Polska


Generic medicines — equivalent pharmaceuticals
you can rely on ... and afford!

EGA is pleased to present this digital video presentation to you on how the generic medicines industry is working to provide high-quality affordable medicines to millions of Europeans while stimulating competitiveness and innovation in the pharmaceutical sector.

Generic medicines and original branded products contain the same active substance, must meet the same standards of quality, safety and efficacy and comply with the same stringent rules of production and pharmacovigilance.

Generic medicines producers invest 6-16% of revenues to Research & Development to ensure the quality, safety and efficacy of off-patent medications. Competition from generic medicines drives the search for new and more effective pharmaceuticals. Equivalent generic medicines are typically 20-90% less expensive than brand-name products. They save EU patients €25 billion a year, and create the budget headroom needed to pay for expensive products, treatments and services.

Here is what you will find out:

  • What are generic medicines? How are they produced?
  • How is their quality, safety & efficacy guaranteed?
  • Why do equivalent generic medicines cost patients and healthcare systems so much less than originator products?
  • Why are affordable equivalent medicines so very important to you and to the future of our European healthcare?
Copyright © 2004 EGA - European Generic medicines Association   •     •  Cascading Pop-up Menus ©Angus Turnbull